RE: Update29 Jan 2025 17:15
And what we've learned is we can tune the activity and the p k of this molecule to select the molecule that will have the most appropriate and optimal activity to take forward to the clinic. And therefore, we can achieve this release in a FAP dependent way, with very limited, systemic exposure and effective tumor cell killing.
Mind blowing..!